Sound Choice Pharmaceutical Institute

The Sound Choice Pharmaceutical Institute (SCPI) is a U.S.-based non-profit organization operating as a 501(c)3 entity. Its mission includes working to end human trafficking and exploitation in biomedical research and commercial products, with a focus on the ethical considerations of using human fetal material in medical products.

Mission and Values

SCPI aims to end exploitation and eliminate needless suffering by promoting awareness about the use of fetal human material in drug development and commercialization. They advocate for consumer rights to know the composition of medical products, including residual human DNA, and to have access to alternative, ethically acceptable treatments.

Research and Activities

The institute conducts research on the health risks associated with the use of aborted fetal material in vaccines and other products. This includes studying the potential for immune system activation and genetic mutations when residual human DNA is present in these products. SCPI supports advancements in adult stem cell research, seeking alternatives to fetal-derived materials.

Leadership

SCPI is led by Dr. Theresa Deisher, a renowned expert in adult stem cell therapies and regenerative medicine. With over 30 years of experience in pharmaceutical research, Dr. Deisher has been involved with numerous leading biotechnology companies and holds multiple patents in the field.

Goals and Impact

By promoting awareness and advocating for ethical practices in biomedical industries, SCPI seeks to create a safer and more morally aligned approach to medical research and product development. The organization encourages public support for its mission to provide consumers with informed choices about the medicines and products they use.

Ratings and Recognition

Sound Choice Pharmaceutical Institute has received a rating from Charity Navigator, reflecting its status as a recognized charitable organization in the United States.